Vanguard Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Vanguard Asset Management's ELV Position: Q2 2026 in Review
Vanguard Asset Management reduced its Elevance Health (ELV) stake by 3.1% in Q2 2026, selling an estimated $5.19M and leaving 432,196 shares worth $167M. The position accounts for 0.11% of the portfolio, ranked #150.
Vanguard Asset Management first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Vanguard Asset Management held 432,196 shares of Elevance Health worth $167M as of Q2 2026.
- Vanguard Asset Management sold 13,994 Elevance Health shares in Q2 2026, an estimated $5.19M.
- Elevance Health made up 0.11% of Vanguard Asset Management's portfolio in Q2 2026, its #150 holding.
- Vanguard Asset Management first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
- 1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.